Peer Review History
| Original SubmissionJuly 15, 2025 |
|---|
|
Dear Dr. Barragan Ibañez, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. The reviewers have requested some clarifications about how some of calculations performed and presented, as well as some methodological details needing more exploration. The reviewers also request a more balanced assessment of the utility of frequentist methods alongside Bayesian analyses. Please submit your revised manuscript by Nov 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Christopher Kirk, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 3. Please note that PLOS One has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, we expect all author-generated code to be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 5. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 6. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories . 7. Please include a caption for figure 5. 8. Please ensure that you refer to Figure 5 in your text as, if accepted, production will need this reference to link the reader to the figure. 9. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 10. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 11. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I enjoyed reading your paper and I think it makes a valuable contribution to the literature on Bayesian methods in intervention research. The tutorial approach effectively demonstrates practical implementation of Bayes factors for hypothesis testing in cluster randomised trials, addressing an important methodological gap. Nonetheless, several issues require attention before I can recommend publication. Critical technical correction required The most important issue is the contradiction regarding fractional prior specification. You state that b = 1/Neff in the theoretical section but claim b = 1 by default in the implementation section. Since fractional Bayes factors require 0 < b < 1 by construction, this needs immediate correction. Please clarify how Neff is computed for your mixed model and consider providing a brief sensitivity analysis showing stability of Bayes factor conclusions across a small grid of b values. Methodological clarification needed Your analysis uses change scores with cluster-level random intercepts and covariate adjustment. Please briefly discuss why this approach was chosen over alternatives (ANCOVA-type analysis or longitudinal mixed models with time × group interactions) that are often preferable for precision in two-time-point CRTs. Additionally, specify which degrees of freedom adjustment method was used and explicitly define which variance component was used for Cohen's d standardisation in your clustered, covariate-adjusted setting. Since your outcome is a sum of eight three-category items, please acknowledge the approximate-continuity assumption underlying the linear mixed model and note that ordinal alternatives exist when scale properties are uncertain. Sample size methodology Your sample-size planning assumes equal cluster sizes and fixes planning at the minimum observed cluster size (4) rather than the empirical average (nearly 12). Please justify this choice and comment briefly on how unequal cluster sizes affect power. The assumption of equal cluster sizes in simulations should be stated explicitly, with comment on the likely impact of non-zero coefficients of variation in cluster size. Presentation improvements Ensure consistent reporting of Bayes factor magnitudes throughout the text. The term "fail-safe hypotheses" is non-standard and potentially confusing; use "complement" for Hc and "unconstrained" for Hu while explaining that including Hc ensures coverage of the entire parameter space. Your criticism of null hypothesis significance testing, while valid, occasionally becomes one-sided. A more balanced discussion acknowledging scenarios where traditional methods might be preferable would strengthen credibility. Reference established, though still heuristic, guidelines for BF interpretation (e.g., Jeffreys' scales or others). This will give readers a concrete starting point, even while you correctly maintain that these scales are interpretive aids, not rigid rules. Implementation guidance The paper would benefit from expanded discussion of practical implementation challenges, particularly computational requirements for simulation-based sample size determination. Consider adding guidance on common pitfalls for practitioners attempting to implement these methods. Minor technical notes The relationship between different Bayes factor variants could be better explained. The ICC values used for planning (0.054) versus observed (0.042) should be clearly distinguished throughout. Table 1 caption formatting needs correction for footnote markers. Despite these issues, your manuscript provides clear exposition of Bayes factors via fit and complexity, demonstrates practical utility through a well-executed worked example, and extends the tutorial with valuable simulation-based sample-size determination methodology. With the corrections outlined above, particularly addressing the fractional prior specification and adding the requested methodological clarifications, this will serve as an excellent resource for behavioral and health researchers considering Bayesian approaches to intervention studies. Finally, your criticism of null hypothesis significance testing, while valid, occasionally becomes one-sided. Acknowledging that there are scenarios where traditional methods might be preferable is a mature and clarifying recommendation that would strengthen your paper's credibility and provide a more balanced discussion for your audience. Reviewer #2: This is a tutorial on applying Bayesian hypothesis testing, specifically using the Bayes factor, to behavioral intervention studies, with a focus on cluster randomized trials (CRTs). The paper is well-structured, clearly written, and addresses a critical need in the research community by providing a practical alternative to null hypothesis significance testing (NHST). Please find my comments below: 1)The paper mentions that the prior is calibrated using the effective sample size (N_eff) but does not provide an explicit formula for how N_eff is calculated in the context of a CRT. Please include the formula relating N_eff to the number of clusters, cluster size, and ICC. 2) Equation 5: Equation 5 currently indicates that both conditions must be satisfied simultaneously. However, the subsequent explanation states that for Hypothesis Set 2, either condition alone is sufficient to support the hypothesis. The equation as written does not capture this distinction. The authors should modify Equation 5 to explicitly represent separate criteria for the two hypothesis sets, or add an explanatory note immediately after the equation clarifying how the rule differs between Hypothesis Sets 1 and 2. 3) Line 484: Clarify whether 0.603 is a typographical error for 0.590, or if it was calculated differently. If different, explain which calculation method produced 0.603 and why it differs from Table 1. 4) Figure 4: Figure 4 shows sample size remains constant as ICC increases for hypothesis set 2. This contradicts established CRT theory and requires explanation. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Dear Dr. Barragan Ibañez, Please submit your revised manuscript by Jan 29 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Christopher Kirk, PhD Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: (No Response) ********** Reviewer #1: Thank you for the revisions, you have adressed my questions and concerns. Pointing to the interactive Shiny app provides readers with a useful pedogogical tool, but it took me some time to find the shiny app. I would explicitly include a link for readers to easily follow: https://utrecht-university.shinyapps.io/BayesSamplSizeDet-CRT/ Reviewer #2: The authors have revised the manuscript adequately. There is only one minor comment. While the authors explained the line in Figure 4 is flat because of a floor effect in their simulation algorithm, they did not explicitly include this "minimum boundary" explanation in the main text. Please refine the text stating that the minimum sample size investigated (8 clusters) was sufficient to meet the power criterion across the tested ICC range. Additionally, please include a brief note in the Figure 4 caption and the main text clarifying that this flat line represents the lower bound of the simulation grid, which effectively masks the minor influence of the ICC at this specific effect size. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Design and Analysis of Behavioral Intervention Studies: a Bayesian Approach PONE-D-25-33347R2 Dear Dr. Barragan Ibañez, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards and congratulations, Christopher Kirk, PhD Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: (No Response) ********** Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-33347R2 PLOS One Dear Dr. Barragan Ibañez, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Christopher Kirk Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .